These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis. Zervos M, Martinez FJ, Amsden GW, Rothermel CD, Treadway G. Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096 [Abstract] [Full Text] [Related]
26. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Llor C, Moragas A, Hernández S, Bayona C, Miravitlles M. Am J Respir Crit Care Med; 2012 Oct 15; 186(8):716-23. PubMed ID: 22923662 [Abstract] [Full Text] [Related]
28. Systematic review and meta-analysis of prophylactic antibiotics in COPD and/or chronic bronchitis. Lee JS, Park DA, Hong Y, Jo KW, Lee SW, Huh JW, Oh YM, Lee SD. Int J Tuberc Lung Dis; 2013 Feb 15; 17(2):153-62. PubMed ID: 23317949 [Abstract] [Full Text] [Related]
29. Short-course fluoroquinolones in acute exacerbations of chronic bronchitis. Gotfried MH, Grossman RF. Expert Rev Respir Med; 2010 Oct 15; 4(5):661-72. PubMed ID: 20923343 [Abstract] [Full Text] [Related]
34. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I. Clin Ther; 2008 May 15; 30(5):868-83. PubMed ID: 18555934 [Abstract] [Full Text] [Related]
35. Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis. Arandjus C, Black PN, Poole PJ, Wood Baker R, Steurer-Stey C. Respir Med; 2006 Oct 15; 100(10):1671-81. PubMed ID: 16934969 [Abstract] [Full Text] [Related]
36. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Müller B, Scherr A, Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J. JAMA; 2013 Jun 05; 309(21):2223-31. PubMed ID: 23695200 [Abstract] [Full Text] [Related]
37. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease. Chelidze K, Jgarkava M. Georgian Med News; 2008 Jun 05; (159):27-30. PubMed ID: 18633147 [Abstract] [Full Text] [Related]
38. [Qualitatively reliable study proves: in chronic bronchitis or COPD--standardized Myrtol]. MMW Fortschr Med; 2004 May 06; 146(19):56-7. PubMed ID: 15357482 [No Abstract] [Full Text] [Related]
39. [A randomized comparative study of 3 days of azithromycin treatment and 10 days of cefuroxime treatment in exacerbations in patients with chronic obstructive pulmonary disease]. Alvarez Gutiérrez FJ, Soto Campos G, del Castillo Otero D, Sánchez Gómez J, Calderón Osuna E, Rodríguez Becerra E, Castillo Gómez J. Med Clin (Barc); 1999 Jul 03; 113(4):124-8. PubMed ID: 10472596 [Abstract] [Full Text] [Related]
40. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C. Respir Med; 2008 Aug 03; 102(8):1099-108. PubMed ID: 18614347 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]